Electronic Drug Delivery Systems Market Projected To Raise At USD 15.4 Billion By 2027


 San Francisco, 1 Dec 2020: The Report Electronic Drug Delivery Systems Market Size, Share & Trends Analysis Report by Product Type (Auto Injectors, Injection Pens), By Application (Diabetes, CVDs), By Distribution Channel, And Segment Forecasts, 2020 - 2027

The global electronic drug delivery systems market size is expected to reach USD 15.4 billion by 2027 registering a CAGR of 8.9%, according to a new report by Grand View Research, Inc. Technological advancements allowing easy self-administration technologies, mainly in infusion pumps and auto injectors that help in large-volume and high-viscosity biologic drugs have created a potential market opportunity for the companies. Approvals of novel drug formulations for use in infusion pumps allow a novel treatment option, thereby advancing diabetes care in adults.

In October 2019, Novo Nordisk received the U.S. Food and Drug Administration approval for Fiasp, insulin injection for use in insulin pumps for patients with type 1 and 2 diabetes. Moreover, the innovative wearable infusion pumps allow the patients to wirelessly connect to smartphone apps. This enables healthcare professionals to track patient data and tailor specific therapies as per individual requirements. The aforementioned factors have augmented the demand for electronic drug delivery systems globally. However, automated pumps may have risks of wrong dosage with technical glitches and might lead to adverse drug reactions. This may hinder the market growth.

Access Research Report of Electronic Drug Delivery Systems Market https://www.grandviewresearch.com/industry-analysis/electronic-drug-delivery-systems-market

Electronic Drug Delivery Systems Market Report Highlights

  • North America accounted for the largest share in 2019 owing to high prevalence of chronic diseases, such as diabetes, heart diseases, asthma, and COPD
  • Key companies are adopting several strategies, such as expansion of production facilities, to cater to the increasing product demand and thus gain a significant share in the global market
  • By product type, the wearable infusion pump segment led the market as these pumps provide a cost-effective alternative with the convenience of a disposable injection pen and prefilled syringe
  • By application, diabetes segment is expected to register the fastest CAGR due to rising number of diabetic patients across the globe and frequent drug administration required to manage the condition
  • By distribution channel, retail pharmacies held the largest market share as they include major pharmacy chains

List of Key Players of Electronic Drug Delivery Systems Market

  • Bayer AG
  • Gerresheimer AG
  • Medtronic PLC
  • Elcam Medical Group
  • Novo Nordisk
  • Insulet Corp.
  • Becton, Dickinson and Company
  • Sanofi S.A.
  • Unilife Corp.

Access Press Release of Electronic Drug Delivery Systems Market @ https://www.grandviewresearch.com/press-release/global-electronic-drug-delivery-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Comments

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.